Search Results 1271-1280 of 19404 for Hemoglobin

1. Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies - Mayo Clinic

   Hemoglobin (HgB) ≥ 9.0 gm/dL; Alkaline phosphatase ≤ 2.5 x ULN; Creatinine clearance > 50 ml/min, by either Cockcroft-Gault formula or 24-hour urine ...

2. A Phase I, Multi-Center, Open Label, Dose De-escalation and Expansion Study of Gemcitabine and Cisplatin with AG120 or Pemigatinib for Advanced Cholangiocarcinoma - Mayo Clinic

   Hemoglobin ≥ 8 g/dL (obtained ≤ 21 days prior to registration). Serum total bilirubin ≤ 2.0 x upper limit of normal (ULN), unless considered due to ...

3. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Hemoglobin ≥ 8 g/dL; subjects may receive red blood cell transfusions as clinically indicated per institutional guidelines but screening hemoglobin should ...

4. A Study Combining Tofacitinib with Gemcitabine for the Treatment of Pancreas Cancer in Patients who are Losing Weight - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL; Cohort II (MTD) only PT/INR ≤ 1.5 x ULN. Ability to provide written informed consent; Willing to return to Mayo Clinic for follow up ...

5. Phase 2 Study Of ALXN2030 In Patients With Antibody-Mediated Rejection After Kidney Transplantation - Mayo Clinic

   * Hemoglobin < 8 g/dL * Platelets < 100 × 109/L * Leucocytes < 3 × 109/L * Neutrophils < 1.5 × 109/L * Multiorgan transplant recipient (except for previous ...

6. Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis - Mayo Clinic

   Unexplained anemia (<10 g/dL) or documented drop in hemoglobin >1 g/dL); Increased diffusing capacity of carbon dioxide. Provision of informed consent by ...

7. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   Hemoglobin ≥8.0 g/dL;; Total bilirubin ≤ 1.5 x ULN;; ALT and AST ≤ 2.5 x ULN. *Cockcroft-Gault Equation: Creatinine clearance for males = (140 - age)( ...

8. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA) - Mayo Clinic

   - Hemoglobin (Hgb) level ≤10.0 grams/deciliter (pre-transfusion). - Evidence of classical complement pathway activation. - Evidence of active hemolysis ...

9. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Hemoglobin ≥ 10.0 g/dL (6.2 mmol/L);; Serum total bilirubin ≤ 1.5 × ULN (except subjects with Gilbert syndrome, who can have total bilirubin < 3.0 mg/dL); ...

10. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

    Hemoglobin (Hgb) > 9 g/dL;; Creatinine clearance greater than 45 mL/min by calculation using Cockcroft-Gault formula;; Total bilirubin (TBIL) ≤ 1.5 x upper ...